Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma
暂无分享,去创建一个
[1] Huile Gao,et al. Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT. , 2014, Journal of pharmaceutical sciences.
[2] Fabao Gao,et al. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. , 2014, Molecular pharmaceutics.
[3] Haishan Zhang,et al. A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles. , 2014, Colloids and surfaces. B, Biointerfaces.
[4] Yarong Liu,et al. Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity , 2014, Molecular pharmaceutics.
[5] Shijie Cao,et al. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. , 2014, Biomaterials.
[6] Xin-guo Jiang,et al. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. , 2014, Acta biomaterialia.
[7] Pilju Youn,et al. A Myristoylated Cell-Penetrating Peptide Bearing a Transferrin Receptor-Targeting Sequence for Neuro-Targeted siRNA Delivery , 2014, Molecular pharmaceutics.
[8] Xin-guo Jiang,et al. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[9] Chengwen Sun,et al. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[10] G. Kibria,et al. Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[11] Q. Zhang,et al. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. , 2011, International journal of pharmaceutics.
[12] Zhirong Zhang,et al. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration. , 2011, Molecular pharmaceutics.
[13] G. Kibria,et al. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[14] G. Kibria,et al. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system. , 2011, International journal of pharmaceutics.
[15] Lei Yang,et al. Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles. , 2011, Biomaterials.
[16] H. Harashima,et al. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake. , 2010, International journal of pharmaceutics.
[17] Zhiyuan Zhong,et al. pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[18] Min Zhang,et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. , 2009, Small.
[19] Marilena Loizidou,et al. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.
[20] Yi Yan Yang,et al. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. , 2009, Biomaterials.
[21] S. Futaki,et al. Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment , 2009, The AAPS Journal.
[22] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[23] Vladimir P Torchilin,et al. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.
[24] Kazuo Maruyama,et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. , 2008, International journal of pharmaceutics.
[25] T. Daniels,et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.
[26] R. Essner,et al. The role of surgery in treatment of stage IV melanoma , 2006, Journal of surgical oncology.
[27] R. Bellamkonda,et al. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[28] R. Pérez-Tomás,et al. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. , 2006, Current medicinal chemistry.
[29] I. Ojima,et al. Recent advances in tumor-targeting anticancer drug conjugates. , 2005, Bioorganic & medicinal chemistry.
[30] M. Giacca,et al. Transcellular protein transduction using the Tat protein of HIV-1. , 2005, Advanced drug delivery reviews.
[31] A. Ben-Yehudah,et al. Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy. , 2004, Current cancer drug targets.
[32] N. Oku,et al. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[33] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[34] A. Prochiantz,et al. Transduction peptides: from technology to physiology , 2004, Nature Cell Biology.
[35] R. Schiffelers,et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[36] Hongzhe Sun,et al. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.
[37] D. Jeoung,et al. Mechanism of doxorubicin-induced cell death and expression profile analysis , 2002, Biotechnology Letters.
[38] L. Brodin,et al. Sequential steps in clathrin-mediated synaptic vesicle endocytosis , 2000, Current Opinion in Neurobiology.
[39] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[40] R. Edwards,et al. HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches. , 1999, Biochemical pharmacology.
[41] M. Jackson,et al. Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[42] H. Geerts,et al. Annexin V binding assay as a tool to measure apoptosis in differentiated neuronal cells , 1998, Journal of Neuroscience Methods.
[43] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[44] R. A. Warren,et al. Saturation of the Endocytic Pathway for the Transferrin Receptor Does Not Affect the Endocytosis of the Epidermal Growth Factor Receptor* , 1997, The Journal of Biological Chemistry.
[45] E. Hall,et al. Taxol sensitizes human astrocytoma cells to radiation. , 1992, Cancer research.
[46] D. Coulter,et al. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. , 1992, Cancer research.
[47] D. Deamer,et al. A novel method for encapsulation of macromolecules in liposomes. , 1985, Biochimica et biophysica acta.
[48] G. Gregoriadis,et al. Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. , 1982, Life sciences.
[49] P. Low,et al. Folate receptor-mediated targeting of liposomal drugs to cancer cells. , 2004, Methods in enzymology.
[50] Y. Barenholz,et al. Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes. , 1994 .
[51] J. Carlsson,et al. Liquid-overlay culture of cellular spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.